Transaction Advisory

Connecting Business to Transformation

A team purpose-built to meet your needs

Every Alira Health project team is hand-picked based on the specific requirements, needs, and goals of each project.

This allows us to effectively complement your expertise with a powerful combination of strategists, doctors, bankers and scientists from around the world.

Your dedicated team provides a complete continuum of support with a 360° approach that is tailored to your business and targeted for growth.

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Benjamin Chambon
Benjamin Chambon
Chief Commercial Officer, Executive Vice President of the Transaction Advisory
We integrate our M&A and Investment Banking expertise with in-depth market, medical, and science understanding to advise you every step of the way.

Related news

M&A
Publications August 3, 2021
What You Should Know Before Choosing a Healthcare Transaction Advisory Firm
What’s most important when selecting a firm for your next transaction? Global experience, staff profiles, technical expertise? To learn more read our latest TAD Infographic.
M&A MedTech Pharma
News April 12, 2021
Alira Health Strengthens its Growth Strategy with a $35M Funding, led by Creadev
Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.
M&A Pharma
News December 20, 2020
We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS
We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.
M&A
News November 29, 2020
We Announce our Role as Strategic Advisor to Benvic in the Acquisition of Luc & Bel
We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel.
M&A
Publications November 1, 2020
Five Key Success Factors for Managing Transactions in Full Virtual Mode
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
M&A MedTech
Publications October 10, 2020
Q3 2020 Medical Device Contract Development and Manufacturing M&A Report
Despite the COVID-19 pandemic, M&A activity in the global CDMO industry has been exceptionally strong in 2020 with a record number of transactions completed during the third quarter alone.
M&A
News September 11, 2020
We Announce our Role as Advisor to Sagard NewGen
We are pleased to announce our role as Advisor to Sagard NewGen for the equity investment in Laboratoires Delbert. This recent capital raise of €40m supports the company’s growth(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.